{"nct_id":"NCT02443883","title":"A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2015-07-07","start_date_type":"ACTUAL","primary_completion_date":"2016-11-18","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}